South America: Food, Drugs, Healthcare, Life Sciences

La Secretaría de Salud de México publicó un nuevo acuerdo que regula el uso de aditivos y coadyuvantes en alimentos, bebidas y suplementos alimenticios. El documento establece once anexos con sustancias permitidas, especifica categorías de productos y dosis máximas, y define procedimientos para solicitar el uso de aditivos no listados. ¿Cómo afectará esta regulación a la industria alimentaria y qué cambios deben implementar los fabricantes antes de su entrad

The Brazilian Patent and Trademark Office (BRPTO) has launched a collaborative examination initiative with Uruguay's DNPI to expedite patent application reviews in pharmaceuticals, biotechnology, and natural products.

Recent anti-doping cases reveal the harsh reality facing professional athletes who fail to properly document and verify substances entering their bodies. Even when prescribed by team doctors, players bear ultimate responsibility for prohibited substances, with career-ending consequences for those who delegate this critical duty.

La Secretaría de Salud de México publicó un nuevo acuerdo que regula el uso de aditivos y coadyuvantes en alimentos, bebidas y suplementos alimenticios. El documento establece once anexos con sustancias permitidas, especifica categorías de productos y dosis máximas, y define procedimientos para solicitar el uso de aditivos no listados. ¿Cómo afectará esta regulación a la industria alimentaria y qué cambios deben implementar los fabricantes antes de su entrad

The Brazilian Patent and Trademark Office (BRPTO) has launched a collaborative examination initiative with Uruguay's DNPI to expedite patent application reviews in pharmaceuticals, biotechnology, and natural products.

The Brazilian Patent and Trademark Office (BRPTO) and Peru's INDECOPI have launched a collaborative examination initiative for patent applications in pharmaceuticals, biotechnology, and natural products. This partnership, formalized through a 2025 Bilateral Cooperation Memorandum, will provide expedited technical examination for qualifying PCT applications that entered the national phase between October 2022 and July 2023.

A Lei nº 15.471/2026 institui a Ensceis, transformando o poder de compra do SUS em instrumento de política industrial para reduzir a dependência produtiva e tecnológica do Brasil em saúde. O KLA preparou um e-book detalhando os principais impactos da nova estratégia nacional, incluindo credenciamento de empresas estratégicas, produtos prioritários e parcerias de transferência de tecnologia.

This page appears to be a security verification checkpoint that temporarily blocks access while validating the incoming request. The system implements protective measures to distinguish legitimate users from automated traffic or potential security threats.

On June 21, 2026, Statute #15,471 was published, resulting from Bill #2,583/20. The new statute established the National Health Strategy for the Health Economic-Industrial Complex (ENSCEIS in the Portuguese acronym). The term “established” is not technically accurate, since, in substance, the strategy had already been created in 2023 by Decree #11,715, which in turn merely consolidated pre-existing programs, such as the Productive Development Partnerships (PDPs) dating back to 2008.